Investigator Driven Randomized Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection (the GAME CHANGER trial) (2018–2021)

Grant type:
Shionogi & Company, Limited
Researchers:
Funded by:
Shionogi & Company, Limited